Dianthus Therapeutics, Inc.

Dianthus Therapeutics, Inc.

78.50
EUR
-3.00
(-3.68%)
-3.46EPS
4.36BMarket Cap
Mar 16Next Earn

Dianthus Therapeutics, Inc. Documents

Q1 FY2026 · Presentation

91 pages

Read Dianthus Therapeutics, Inc.'s results firsthand

Preview the first 2 pages of this presentation
Create a free account to start reading

Full documents are included with Professional

Q1 FY2026 documents